Data Dashboard
HPV Vaccine Coverage Male/Female (adolescents age 13-17 years)
Female 1-dose | Female Up-To-Date | Male 1-dose | Male Up-To-Date | |
Kansas | 73.5% | 61.9% | 73.4% | 59.5% |
United States | 77.8% | 64.6% | 74.4% | 60.6% |
HPV Vaccine Coverage Both Male and Female (adolescents age 13-17 years)
Male and Female Up-To-Date | |
Kansas | 60.7% |
United States | 62.6% |
Key Vaccines Coverage
(combined 7-vaccine series for children 19-35 months | Tdap and menACWY for adolescents age 13-17 years | influenza for all persons over 6 months age)
Combined 7- vaccine series* |
Tdap | MenACWY | Influenza | |
Kansas | 73.0% | 87.8% | 86.0% | 52.9% |
United States | 75.4% | 89.6% | 89.0% | 51.4% |
Human papillomavirus (HPV) vaccination coverage among adolescents 13-17 years by State, HHS Region, and the United States, National Immunization Survey-Teen (NIS-Teen), 2022
Combined 7-vaccine Series Vaccination coverage among children 19-35 months by State, HHS Region, and the United States, National Immunization Survey-Child (NIS-Child), 2017
Tetanus-diphtheria toxoids (Td) or tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccination coverage among adolescents 13-17 years by State, HHS Region, and the United States, National Immunization Survey-Teen (NIS-Teen), 2022
Meningococcal conjugate (MenACWY) vaccination coverage among adolescents 13-17 years by State, HHS Region, and the United States, National Immunization Survey-Teen (NIS-Teen), 2022
Influenza vaccination coverage estimates for persons 6 months and older by state, HHS region, and the United States, National Immunization Survey-Flu (NIS-Flu) and Behavioral Risk Factor Surveillance System (BRFSS), 2020-21 influenza season
Female | Male | Both Male & Female | ||||
1-dose | Up-To-Date | 1-dose | Up-To-Date | Up-To-Date | ||
Kansas | 73.5% | 61.9% | 73.4% | 59.5% | 60.7% | |
United States | 77.8% | 64.6% | 74.4% | 60.6% | 62.6% | |
HP2030 Target | - | 80.0% | - | 80.0% | 80.0% |


MenACWY | |
Kansas | 85.9% |
United States | 88.6% |
Target | 80.0% |
Meningococcal conjugate (MenACWY) vaccination coverage among adolescents 13-17 years by State, HHS Region, and the United States, National Immunization Survey-Teen (NIS-Teen), 2022

Tdap | |
Kansas | 89.2% |
United States | 89.9% |
Target | 90.0% |
Tetanus-diphtheria toxoids (Td) or tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccination coverage among adolescents 13-17 years by State, HHS Region, and the United States, National Immunization Survey-Teen (NIS-Teen), 2022
Children Age Group (Years) | |||
6 mo - 4 yrs | 5-12 yr | 13-17 yr | |
Kansas | 70.7% | 56.9% | 42.5% |
United States | 66.7% | 58.4% | 49.8% |
Target | 70% | 70% | 70% |
Age Group (Years) | |||
18+ | 18-64 | 65+ | |
Kansas | 52.0% | 45.0% | 75.2% |
United States | 49.4% | 42.0% | 73.9% |
HP2020 Target | 70% | 70% | 70% |
Age Group (Years) | ||||||
18-24 | 25-34 | 35-44 | 45-54 | 55-64 | 65+ | |
Kansas | 39% | 35% | 38% | 41% | 52% | 66% |
Education Level | ||||
Less than high school |
High school graduate or G.E.D |
Some College |
College Graduate |
|
Kansas | 37% | 40% | 45% | 57% |
Insurance Status | ||
Insured | Uninsured | |
Kansas | 51% | 19% |
Kansas | ||
Race | White | 46% |
Black or African American | 41% | |
Other/Multi-Race | 41% | |
Ethnicity | Hispanic | 38% |

4+DTaP | 3+Polio | 1+MMR | Hib-FS | 3+HepB | 1+Var | 4+PCV | 2+HepA | Rotavirus | |
Kansas | 86% | 94% | 94% | 80% | 98% | 94% | 89% | 76% | 76% |
United States | 88% | 95% | 94% | 83% | 94% | 94% | 87% | 80% | 77% |
Hib-FS | 3+HepB | 1+Var | |
Kansas | 84% | 95% | 92% |
United States | 84% | 94% | 94% |
4+PCV | 2+HepA | Rotavirus | |
Kansas | 86% | 80% | 81% |
United States | 86% | 78% | 77% |
ChildVaxView

Age Group (Years) | ||
18-64yrs (At risk) |
65+yrs | |
Kansas | 32% | 74% |
United States | 29% | 70% |
HP2020 Target | 60% | 90% |
* - At risk individuals: Individuals who have self-reported having one or more of the following: 1 )having current asthma; 2)ever being told by a health professional they have diabetes, myocardial infarction, angina or coronary heart disease; 3) being a current smoker; or 4) ever being told by a health professional they have chronic obstructive pulmonary disease, emphysema or chronic bronchitis, or cancer (excluding skin cancer).
Pneumococcal vaccination coverage among adults 18-64 years at increased risk and ≥65 years, Td and Tdap vaccination coverage among adults ≥18 years, and shingles vaccination among adults ≥60 years, by State, HHS Region, and the United States, BRFSS, 2020
The Kansas Department of Health and Environment conducts Immunization Coverage Assessments into the statewide vaccination records of various age groups across the state. The reports aim to provide an understanding of the vaccination coverages in the state and how they compare to the recommendations by the Advisory Committee for Immunization Practices (ACIP) and the American College Health Association (ACHA). A primary benefit to these reports is the ability to see vaccination coverage at a local level (e.g. by county), which is not possible through national resources. Click on the links below to view a highlight of the respective report's data, and a link report itself.
Kindergarten Immunization Coverage Survey
Dashboard and Reports:
Kindergarten Immunization DashboardKindergarten Immunization Rates One Pager (2021-2022)
Kindergarten Immunization Coverage Survey (2018-2019 School Year)
Overview:
The Kindergarten Immunization Dashboard shows data from the Kindergarten Immunization Coverage Survey. The survey is a collection of vaccination records for children enrolled in a kindergarten class at Kansas public and private schools during the school year. Statewide vaccination coverage levels are calculated and various factors assessed. This study includes children between the ages of five and seven.
Retrospective Immunization Coverage Survey
Overview:
The Retrospective Immunization Coverage Survey is an assessment conducted annually to assess the vaccination coverage among current kindergarten students when they were 24 and 35 months of age. The population for this study includes current kindergarten students between the ages of five and seven on the first day of the academic year enrolled in either a public or private school in Kansas.
Data Highlights:
This report provides insight into the statewide vaccination coverage of kindergarten students at the age of 24 and 35 months (Seen below in Figure 3).
This report also provides a statewide vaccination coverage map of kindergarten students at the age of 24 and 35 months by county for the DTaP4, HepA2, HepB3, Hib3, IPV3, MMR1, PCV4, and VAR1 vaccines. (Seen below in Map 9).
This report also provides maps and data tables containing the vaccination rate of kindergarten students at the age of 35 months by county and vaccine type, see the full survey report linked below for additional data.
Link to Full Report:
Retrospective Immunization Coverage Survey (2018-2019)Assessment of Immunization Policies of
Four-Year Colleges and Universities in Kansas
Overview:
The Assessment of Immunization Policies of Four-Year Colleges and Universities in Kansas consisted of a survey that was developed and administered to all four-year colleges and universities, both public and private, to understand the institution's immunization policy. The purpose of this study was to determine the current vaccine-preventable disease immunization requirement of four-year colleges and universities in the state.
Link to Full Report:
Assessment of Immunization Policies of Four-Year Colleges and Universities in Kansas (2012)
"The VaxView websites provide vaccination coverage data for all ages. Monitoring coverage for recommended vaccinations across the country helps CDC assess how well local areas, states, and the nation are protected from vaccine-preventable diseases." (CDC)